Stocktoria

LENSAR, Inc. LNSR

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-09-21

LENSAR, Inc. statistics & valuation

Market cap$68.1M
P / S1.2×
Net margin-58.7%
FCF margin-25.5%
Return on capital-79.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-48.00% -75.00% -56.90% -56.30% -34.10% -58.70% -58.70% 2019202020212022202320242025
Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-41.60% -70.10% -57.00% -57.10% -29.00% -19.90% -42.10% 2019202020212022202320242025
Return on equity (%)
-29.40% -35.70% -47.40% -43.00% -645.90% 2019202020212022202320242025
Shares outstanding
1.1M 10.9M 11.0M 11.1M 11.3M 11.7M 12.0M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-42.40% -25.00% -29.50% -35.70% -20.70% -47.40% -48.00% 2019202020212022202320242025
Free cash flow margin (%)
-42.50% -53.70% -27.10% -42.30% -23.50% -4.50% -25.50% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$2.09 -$1.96 -$1.31 -$2.73 -$2.87 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-42.1%-19.9%-29.0%-57.1%-57.0%-70.1%-41.6%
Net margin-58.7%-58.7%-34.1%-56.3%-56.9%-75.0%-48.0%
FCF margin-25.5%-4.5%-23.5%-42.3%-27.1%-53.7%-42.5%
Return on assets-48.0%-47.4%-20.7%-35.7%-29.5%-25.0%-42.4%
Return on equity131.7%-645.9%-43.0%-47.4%-35.7%-29.4%48.0%
Current ratio1.152.803.992.955.146.902.19

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.